I specialise in Data & Information with over a decade of Investment Banking experience across private M&A, public takeovers, and corporate divestitures. I joined Raymond James at the end of 2017 as part of the founding team for the launch of their Investment Banking team in London. I started my career at Deloitte as a school leaver and qualified as a Chartered Accountant by the age of 21.Data & Information deals include:* Carve-out of Insurance Insider from Delinian (backed by Epiris) by ECI* Acquisition of BRP by aosphere (backed by Inflexion, Endicott and Allen & Overy)* Acquisition of FDM by Inflexion* Sale of LBR (backed by LLCP) to ICG* Acquisition of With Intelligence (backed by ICG) by Motive Partners* Public takeover of Euromoney Institutional Investor plc for £1.7bn by the consortium of Astorg and Epiris with subsequent carve out of Fastmarkets and Delinian * Sale of AGDATA (backed by Vista) to LLCP * Sale of OneOcean (backed by Equistone) to Lloyd’s Register* Divestment for Informa plc of Barbour ABI to InfoPro* Acquisition of Achilles (backed by Hg) by Bridgepoint* Acquisition of IWSR (backed by FPE) by Bowmark * Carve-out of Ascential plc's Built Environment and Policy division through the divestments of Groundsure to ATI Global, Glenigan to Byggfakta (backed by TA Associates & Stirling Square) and DeHavilland to Bridgepoint* Sale of a significant minority stake in Reward to Verisk * Public takeover of Haynes Publishing plc by InfoPro* Sale of AgriBriefing to Ares, Horizon, and Management* Acquisition of Argosy assets from Simplify Compliance by PEl * Acquisition of PEl by BridgepointOther deals include:* Sale of LoopMe to Mayfair Equity Partners* Sale of Altius to Avanade (Accenture & Microsoft JV)* Sale of Instinctif Partners (backed by Vitruvian) to LDC * Public takeover of Sanderson Group plc by Aptean (backed by TA Associates and Vista)* Public takeover of Communisis plc by OSG (backed by Aquiline Partners)* Carve-out of Rhapsody from Orion Health (NZ listed) by Hg and minority investment in Orion Health's Population Health business